Year: 2015
Type: article
Abstract: Human infections caused by parasitic protozoans and helminths are among the world's leading causes of death.More than a million people die each year from diseases like malaria and neglected tropical diseases like leishmaniasis, trypanosomiasis, and schistosomiasis.Patients also endure disabilities that cause lifelong suffering and that affect productivity and development [1].More insidiously, parasites generate important economic losses, since they often also infect commercially valuable animals.Worldwide, exposure to parasites is increasing due to growing international travel and migrations, as well as climate changes, which affect the geographic distribution of the parasite vectors.The parasitic threat is also aggravated by the rise of the immunocompromised population, which is particularly sensitive to parasite infections (e.g., individuals with AIDS and other immunodeficiencies).A common feature of protozoan parasites and helminths is the synthesis of glycoconjugates and glycan-binding proteins for protection and to interact and respond to changes in their environment.To address the many challenges associated with the study of the structure, the biosynthesis, and the biology of parasitic glycans, the authors of this article have established GlycoPar, a European Marie Curie training program steered by some of the world's academic leaders in the field of parasite glycobiology, in close association with European industrial enterprises.The main scientific goal of this network is the description of novel paradigms and models by which parasite glycoconjugates play a role in the successful colonization of the different hosts.By means of a training-through-research program, the aim of the network is to contribute to the training of a generation of young scientists capable of tackling the challenges posed by parasite glycobiology.
Source: PLoS Pathogens
Institutions: University of Lisbon, Instituto de Medicina Molecular João Lobo Antunes, Liverpool School of Tropical Medicine, ETH Zurich, Institute of Microbiology, University of Dundee, Medizinische Hochschule Hannover, SilicoLife (Portugal), Culham Science Centre, Helmholtz Institute for Pharmaceutical Research Saarland, BOKU University, Barcelona Institute for Global Health, Universitat de Barcelona
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,043
Funders: Wellcome Trust, European Commission
OpenAlex ID: W2198337427
